Literature DB >> 30335470

IL-5 Levels in Nasosorption and Sputosorption Correlate with Sputum Eosinophilia in Allergic Asthma.

Jose T Melo1, Tanushree Tunstall2, Marcia M M Pizzichini1, Rosemeri Maurici1, Cristiane C Rocha1, Felipe Dal-Pizzol1, Jessica Gonçalves1, Trevor T Hansel2, Ryan S Thwaites2, Emilio Pizzichini1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30335470      PMCID: PMC6353000          DOI: 10.1164/rccm.201807-1279LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  9 in total

Review 1.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).

Authors:  J Bousquet; N Khaltaev; A A Cruz; J Denburg; W J Fokkens; A Togias; T Zuberbier; C E Baena-Cagnani; G W Canonica; C van Weel; I Agache; N Aït-Khaled; C Bachert; M S Blaiss; S Bonini; L-P Boulet; P-J Bousquet; P Camargos; K-H Carlsen; Y Chen; A Custovic; R Dahl; P Demoly; H Douagui; S R Durham; R Gerth van Wijk; O Kalayci; M A Kaliner; Y-Y Kim; M L Kowalski; P Kuna; L T T Le; C Lemiere; J Li; R F Lockey; S Mavale-Manuel; E O Meltzer; Y Mohammad; J Mullol; R Naclerio; R E O'Hehir; K Ohta; S Ouedraogo; S Palkonen; N Papadopoulos; G Passalacqua; R Pawankar; T A Popov; K F Rabe; J Rosado-Pinto; G K Scadding; F E R Simons; E Toskala; E Valovirta; P van Cauwenberge; D-Y Wang; M Wickman; B P Yawn; A Yorgancioglu; O M Yusuf; H Zar; I Annesi-Maesano; E D Bateman; A Ben Kheder; D A Boakye; J Bouchard; P Burney; W W Busse; M Chan-Yeung; N H Chavannes; A Chuchalin; W K Dolen; R Emuzyte; L Grouse; M Humbert; C Jackson; S L Johnston; P K Keith; J P Kemp; J-M Klossek; D Larenas-Linnemann; B Lipworth; J-L Malo; G D Marshall; C Naspitz; K Nekam; B Niggemann; E Nizankowska-Mogilnicka; Y Okamoto; M P Orru; P Potter; D Price; S W Stoloff; O Vandenplas; G Viegi; D Williams
Journal:  Allergy       Date:  2008-04       Impact factor: 13.146

Review 2.  Severe and Difficult-to-Treat Asthma in Adults.

Authors:  Elliot Israel; Helen K Reddel
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

3.  beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation.

Authors:  Mei Nie; Alan J Knox; Linhua Pang
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

4.  Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?".

Authors:  Sheldon Laurence Spector; Ricardo Antonio Tan
Journal:  J Asthma       Date:  2012-08-20       Impact factor: 2.515

5.  Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.

Authors:  Annette T Hastie; Wendy C Moore; Huashi Li; Brian M Rector; Victor E Ortega; Rodolfo M Pascual; Stephen P Peters; Deborah A Meyers; Eugene R Bleecker
Journal:  J Allergy Clin Immunol       Date:  2013-05-21       Impact factor: 10.793

6.  Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.

Authors:  Parameswaran Nair; Marcia M M Pizzichini; Melanie Kjarsgaard; Mark D Inman; Ann Efthimiadis; Emilio Pizzichini; Frederick E Hargreave; Paul M O'Byrne
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

Review 7.  After asthma: redefining airways diseases.

Authors:  Ian D Pavord; Richard Beasley; Alvar Agusti; Gary P Anderson; Elisabeth Bel; Guy Brusselle; Paul Cullinan; Adnan Custovic; Francine M Ducharme; John V Fahy; Urs Frey; Peter Gibson; Liam G Heaney; Patrick G Holt; Marc Humbert; Clare M Lloyd; Guy Marks; Fernando D Martinez; Peter D Sly; Erika von Mutius; Sally Wenzel; Heather J Zar; Andy Bush
Journal:  Lancet       Date:  2017-09-11       Impact factor: 202.731

8.  A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13).

Authors:  Trevor T Hansel; Tanushree Tunstall; Maria-Belen Trujillo-Torralbo; Betty Shamji; Ajerico Del-Rosario; Jaideep Dhariwal; Paul D W Kirk; Michael P H Stumpf; Jens Koopmann; Aurica Telcian; Julia Aniscenko; Leila Gogsadze; Eteri Bakhsoliani; Luminita Stanciu; Nathan Bartlett; Michael Edwards; Ross Walton; Patrick Mallia; Toby M Hunt; Trevor L Hunt; Duncan G Hunt; John Westwick; Matthew Edwards; Onn Min Kon; David J Jackson; Sebastian L Johnston
Journal:  EBioMedicine       Date:  2017-03-28       Impact factor: 8.143

9.  Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

Authors:  Ian D Pavord; Stephanie Korn; Peter Howarth; Eugene R Bleecker; Roland Buhl; Oliver N Keene; Hector Ortega; Pascal Chanez
Journal:  Lancet       Date:  2012-08-18       Impact factor: 79.321

  9 in total
  4 in total

1.  Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma Exacerbations In Vivo: A Clinical Trial.

Authors:  Jaideep Dhariwal; Aoife Cameron; Ernie Wong; Malte Paulsen; Maria-Belen Trujillo-Torralbo; Ajerico Del Rosario; Eteri Bakhsoliani; Tatiana Kebadze; Mark Almond; Hugo Farne; Leila Gogsadze; Julia Aniscenko; Batika M J Rana; Trevor T Hansel; David J Jackson; Onn Min Kon; Michael R Edwards; Roberto Solari; David J Cousins; Ross P Walton; Sebastian L Johnston
Journal:  Am J Respir Crit Care Med       Date:  2021-12-01       Impact factor: 30.528

2.  Functional Role of Inflammasome Activation in a Subset of Obese Nonsmoking Patients with Severe Asthma.

Authors:  Paolo Ruggeri; Gaetano Caramori
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

3.  Approaches to the assessment of severe asthma: barriers and strategies.

Authors:  Eleanor C Majellano; Vanessa L Clark; Natasha A Winter; Peter G Gibson; Vanessa M McDonald
Journal:  J Asthma Allergy       Date:  2019-08-23

Review 4.  The Role of IgE in Upper and Lower Airway Disease: More Than Just Allergy!

Authors:  Philippe Gevaert; Kit Wong; Lauren A Millette; Tara F Carr
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-18       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.